TORONTO, Feb. 26, 2014 /CNW/ - The following B-Roll is available by Video On-Demand web download:
STORY SUMMARY: Novartis announced today that Bexsero® (Multicomponent Meningococcal B Vaccine [recombinant, adsorbed]) is now available to doctors and pharmacists across Canada. The vaccine is approved for use in individuals from two months through 17 years of age in Canada. Infants, toddlers and adolescents are at the greatest risk of meningococcal serogroup B (MenB) infection. Bexsero® is the first broad-coverage vaccine to help protect against MenB disease. Prior to Bexsero®, vaccines were only available to help protect against meningococcal strains A, C, W and Y.
WEB Video Preview and Download link:
|TIME OF POSTING:||Available Now|
|DATE OF POSTING:||02/26/2014|
All video can be viewed by clicking on the link. Broadcast quality video is available for download by accredited journalists. Please contact [email protected] for access.
STATIONS, FOR FURTHER INFORMATION, PLEASE CALL:
416 642 7893
For assistance with Video On-Demand, please contact CNW at [email protected] or (416) 863-5612.
CNW Video On-Demand http://cnw.pathfireondemand.com provides free, secure and easy-to-use broadcast quality material direct from our website to accredited journalists worldwide.
This material is offered for free and unrestricted news use.
CNW VIDEO SERVICES.
Video with caption: "Video: Bexsero®: First Vaccine to Prevent Meningococcal Serogroup B (MenB) Now Available in Canada". Video available at: http://stream1.newswire.ca/cgi-bin/playback.cgi?file=20140226_C7548_VIDEO_EN_37165.mp4&posterurl=http://photos.newswire.ca/images/20140226_C7548_PHOTO_EN_37165.jpg&clientName=Novartis%20Pharmaceuticals%20Canada%20Inc%2E&caption=Video%3A%20Bexsero%26%23174%3B%3A%20First%20Vaccine%20to%20Prevent%20Meningococcal%20Serogroup%20B%20%28MenB%29%20Now%20Available%20in%20Canada&title=Bexsero%26%23174%3B%3A%20First%20Vaccine%20to%20Prevent%20Meningococcal%20Serogroup%20B%20%28MenB%29%20Now%20Available%20in%20Canada&headline=Free%20VIDEO%20B%2DROLL%20AVAILABLE%20VIA%20CNW%20%2D%20Bexsero%26%23174%3B%3A%20First%20Vaccine%20to%20Prevent%20Meningococcal%20Serogroup%20B%20%28MenB%29%20Now%20Available%20in%20Canada
SOURCE: Novartis Pharmaceuticals Canada Inc.
For further information:
CNW VIDEO SERVICES, TORONTO (416) 863-5612